GlassScriptPhysician profile
Joseph Ling
NPI 1316301765
$14,483.37
in general payments reported to CMS, 2019-2025
12 companies · $6,099 in 2025
The $6,099 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $145 · 2021: $318 · 2022: $74.00 · 2023: $1,488 · 2024: $6,360 · 2025: $6,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $1,554 · Travel and Lodging: $612 · Honoraria: $25.59 · Education: $5.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,750.00 |
| Food and Beverage | $1,554.02 |
| Travel and Lodging | $612.09 |
| Honoraria | $25.59 |
| Education | $5.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $4,621.84 | 2021-2025 | Visumax, Mel 90, Quatera 700 |
| Rxsight INC | $4,615.80 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Carl Zeiss Meditec, INC. | $3,512.47 | 2020-2025 | Visumax, Cirrus Hd-Oct, Humphrey Hfa |
| Bausch & Lomb Americas INC. | $963.47 | 2022-2025 | Stellaris Elite, Teneo, Envista Aspire Iol |
| Alcon Vision LLC | $268.78 | 2021-2025 | Clareon Panoptix Pro, Wavelight Sightmap, Wavelight Plus |
| Ivantis, INC | $134.06 | 2020-2021 | |
| Harrow Eye, LLC | $124.95 | 2025 | Iheezo |
| Abbvie INC. | $118.20 | 2023 | |
| Oyster Point Pharma, INC. | $46.84 | 2023 | Tyrvaya |
| Carl Zeiss Meditec Cataract Technology INC. | $40.87 | 2021-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $31.43 | 2021 | |
| Lensar, INC. | $4.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.